| 发明名称 |
Aryl ureas as kinase inhibitors |
| 摘要 |
<p>This invention relates to new aryl ureas of formula (I) and methods for their synthesis. The compounds are useful in the treatment of (i) raf mediated diseases, for example, cancer, (ii) p38 mediated diseases such as inflammation and osteoporosis, and (iii) VEGF mediated diseases such as angiogenesis disorders.</p> |
| 申请公布号 |
EP1580188(A1) |
申请公布日期 |
2005.09.28 |
| 申请号 |
EP20050007027 |
申请日期 |
2003.02.11 |
| 申请人 |
BAYER PHARMACEUTICALS CORPORATION |
发明人 |
DUMAS, JACQUES;SCOTT, WILLIAM J.;CHIEN, DU-SCHIENG;LEE, WENDY;BJORGE, SUSAN;MUSZA, LASZLO;NASSAR, ALA;RIEDL, BERND |
| 分类号 |
A61K31/44;A61K45/00;A61P9/00;A61P11/00;A61P19/00;A61P19/10;A61P25/00;A61P29/00;A61P35/00;A61P43/00;C07D213/79;C07D213/81;C07D213/89;(IPC1-7):C07D213/79 |
主分类号 |
A61K31/44 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
